Ackermans & van Haaren NV

Ackermans & van Haaren increases its stake in Van Moer Logistics to 40%

19 Oct 2026 01:00:00 By Nasdaq GlobeNewswire

Ackermans & van Haaren: Results of the extraordinary general meeting of 15th October 2026

15 Oct 2026 11:45:00 By Nasdaq GlobeNewswire

Ackermans & van Haaren publishes convening notice for the Extraordinary Shareholder Meeting of October 15, 2026

14 Sep 2026 01:10:00 By Nasdaq GlobeNewswire

Ackermans & van Haaren Trading Update 3Q2025: Excellent results of core participations, FY2025 Outlook confirmed

21 Nov 2025 01:00:00 By Nasdaq GlobeNewswire

Ackermans & van Haaren invests 22 million euros in VKC Nuts

25 Sep 2025 01:00:00 By Nasdaq GlobeNewswire

Ackermans & van Haaren supports MRM Health’s Series B financing round of 55 million euros

04 Sep 2025 01:15:00 By Nasdaq GlobeNewswire

Ackermans & van Haaren commits 20 million US dollars to the second fund of Venturi Partners

02 Sep 2025 01:00:00 By Nasdaq GlobeNewswire

Ackermans & van Haaren: First-Half 2025 Results

29 Aug 2025 01:00:00 By Nasdaq GlobeNewswire

Ackermans & van Haaren: the General Shareholders' Meeting approves all proposed resolutions by a vast majority

26 May 2025 11:45:00 By Nasdaq GlobeNewswire

Ackermans & van Haaren (Trading Update Q1 2025): AvH reports solid start to the year and confirms guidance

22 May 2025 01:00:00 By Nasdaq GlobeNewswire

Ackermans & van Haaren: publication of a transparency notification

04 Apr 2025 11:42:00 By Nasdaq GlobeNewswire

Ackermans & van Haaren grows net profit by 15% in 2024 to 460 million euros.

28 Feb 2025 01:00:00 By Nasdaq GlobeNewswire

Ackermans & van Haaren Trading Update Q3 2024 - AvH is on track towards a net profit well above 400 million euros

22 Nov 2024 01:00:00 By Nasdaq GlobeNewswire

Ackermans & van Haaren and the Delen family confirm their long-term partnership with updated shareholder arrangements in respect of Delen Private Bank and Bank J. Van Breda & Co

21 Nov 2024 01:00:00 By Nasdaq GlobeNewswire

Ackermans & van Haaren invests an additional 5 million euros in Biotalys

14 Oct 2024 02:15:00 By Nasdaq GlobeNewswire

Ackermans & van Haaren: Outstanding results in core participations result in a strong increase of AvH's net profit for 1H2024 to EUR 200 million (+17%)

30 Aug 2024 01:00:00 By Nasdaq GlobeNewswire

Ackermans & van Haaren leads EUR 60 million Series B Financing Round for Confo Therapeutics, a Belgian clinical-stage biopharmaceutical company

26 Jul 2024 01:00:00 By Nasdaq GlobeNewswire

Ackermans & van Haare invests in V.Group, a leading provider of marine support services

17 Jun 2024 01:00:00 By Nasdaq GlobeNewswire

Ackermans & van Haaren: the General Shareholders' Meeting approves all proposed resolutions by a large majority

27 May 2024 12:35:00 By Nasdaq GlobeNewswire

Ackermans & van Haaren reports outstanding Q1-results at both DEME and at the private banks Delen and Van Breda, and gives confirmation of guidance: net profit of 2024 expected to be higher than last year

23 May 2024 01:00:00 By Nasdaq GlobeNewswire